FI865268A - Naeringstillsats foer behandling av uremi. - Google Patents

Naeringstillsats foer behandling av uremi. Download PDF

Info

Publication number
FI865268A
FI865268A FI865268A FI865268A FI865268A FI 865268 A FI865268 A FI 865268A FI 865268 A FI865268 A FI 865268A FI 865268 A FI865268 A FI 865268A FI 865268 A FI865268 A FI 865268A
Authority
FI
Finland
Prior art keywords
acids
uremi
naeringstillsats
amino acids
basic
Prior art date
Application number
FI865268A
Other languages
English (en)
Other versions
FI865268A0 (fi
FI88581C (fi
FI88581B (fi
Inventor
Machenzie Walser
Henri Bermudez
Claude Bordat
Original Assignee
Univ Johns Hopkins
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins, Synthelabo filed Critical Univ Johns Hopkins
Publication of FI865268A0 publication Critical patent/FI865268A0/fi
Publication of FI865268A publication Critical patent/FI865268A/fi
Application granted granted Critical
Publication of FI88581B publication Critical patent/FI88581B/fi
Publication of FI88581C publication Critical patent/FI88581C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI865268A 1985-12-23 1986-12-22 Foerfarande foer framstaellning av en naeringstillsats foer behandling av uremi FI88581C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81216485 1985-12-23
US06/812,164 US4752619A (en) 1985-12-23 1985-12-23 Nutritional supplement for treatment of uremia

Publications (4)

Publication Number Publication Date
FI865268A0 FI865268A0 (fi) 1986-12-22
FI865268A true FI865268A (fi) 1987-06-24
FI88581B FI88581B (fi) 1993-02-26
FI88581C FI88581C (fi) 1993-06-10

Family

ID=25208721

Family Applications (1)

Application Number Title Priority Date Filing Date
FI865268A FI88581C (fi) 1985-12-23 1986-12-22 Foerfarande foer framstaellning av en naeringstillsats foer behandling av uremi

Country Status (14)

Country Link
US (1) US4752619A (fi)
EP (1) EP0227545B1 (fi)
JP (1) JPS62270522A (fi)
KR (1) KR940002661B1 (fi)
AT (1) ATE67088T1 (fi)
AU (1) AU592395B2 (fi)
CA (1) CA1286990C (fi)
DE (1) DE3681420D1 (fi)
DK (2) DK168274B1 (fi)
ES (1) ES2025560T3 (fi)
FI (1) FI88581C (fi)
GR (1) GR3003272T3 (fi)
NO (1) NO865217L (fi)
PT (1) PT83995B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
SE8803143L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Alternativa energisubstrat
SE8803144L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Energisubstrat
GB8906158D0 (en) * 1989-03-17 1989-05-04 Powell & Scholefield Limited Dietary product
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
DE69839922D1 (de) * 1998-01-05 2008-10-02 Univ Johns Hopkins Diätetische ergänzung für dialyse patienten
JP2004527529A (ja) * 2001-04-04 2004-09-09 クリティカル セラピューティックス インコーポレイテッド 急性腎不全を予防するための方法
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
AU2006267613B2 (en) * 2005-07-08 2011-08-11 Toray Industries, Inc. Therapeutic agent and treatment method for ameliorating uremia
SG194028A1 (en) 2011-04-18 2013-11-29 Nestec Sa Nutritional compositions having alpha-hica and eicosapentaenoic acid
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
EP3716966A4 (en) 2017-11-29 2021-08-18 Hull, Edgar, L., Jr. ALPHA-KETOACID COMPOSITIONS FOR THE TREATMENT OF HYPOALBUMINEMIA

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
DE2516027A1 (de) * 1973-04-30 1975-10-16 Univ Johns Hopkins Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper
GB1442154A (en) * 1973-04-30 1976-07-07 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body
DE2759133A1 (de) * 1976-12-31 1978-07-13 Carmelo Prof Giordano Gemisch essentieller aminosaeuren und/oder analoger ketosaeuren und verwendung derselben diaetzusatz bei niereninsuffizienz
US4228099A (en) * 1978-03-17 1980-10-14 The Johns Hopkins University Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
US4320146A (en) * 1978-03-17 1982-03-16 The Johns Hopkins University Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof

Also Published As

Publication number Publication date
ATE67088T1 (de) 1991-09-15
KR940002661B1 (ko) 1994-03-28
KR870005639A (ko) 1987-07-06
CA1286990C (en) 1991-07-30
NO865217L (no) 1987-06-24
EP0227545A2 (en) 1987-07-01
JPS62270522A (ja) 1987-11-24
EP0227545A3 (en) 1988-01-20
ES2025560T3 (es) 1992-04-01
DK622486A (da) 1987-06-24
EP0227545B1 (en) 1991-09-11
AU592395B2 (en) 1990-01-11
AU6691786A (en) 1987-06-25
FI865268A0 (fi) 1986-12-22
NO865217D0 (no) 1986-12-22
FI88581C (fi) 1993-06-10
PT83995A (en) 1987-01-01
GR3003272T3 (en) 1993-02-17
DE3681420D1 (de) 1991-10-17
FI88581B (fi) 1993-02-26
DK622486D0 (da) 1986-12-22
DK168274B1 (da) 1994-03-07
US4752619A (en) 1988-06-21
PT83995B (pt) 1989-09-14

Similar Documents

Publication Publication Date Title
FI865268A (fi) Naeringstillsats foer behandling av uremi.
ES2099022A1 (es) Composiciones farmaceuticas que contienen las sales de acido s(+)-2-(4-isobutilfenil) propionico con aminoacidos basicos.
ES453476A1 (es) Procedimiento para proporcionar una fuente de proteinas en forma concentrada.
ES2058687T3 (es) Composicion nutritiva y su procedimiento de preparacion.
ES2167338T3 (es) Composicion para tratar pacientes con enfermedades hepaticas.
IL77748A (en) Amino acid and peptide derivatives as peptidase inhibitors
ZA867387B (en) Pharmaceutical and dietary composition
NO990940D0 (no) Ernµringssammensetning for fenylketonuripasienter
EP0744396A4 (en) COMPLEX SALTS OF PHOSPHORIC AND AMINO ACIDS AND FOOD ADDITIVES CONTAINING THEM FOR RUMBERS
AU5458786A (en) Liquid dietary calcium supplementation
AU1971988A (en) Pharmaceutical compositions for the treatment of uraemia
FR2556593B1 (fr) Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels
AU7100094A (en) Rumen-bypass fatty acid salt and protein dietary supplement for ruminants
ES2016917A6 (es) Producto alimenticio y procedimiento para preparar productos alimenticios con konjak anadido.
DE3466348D1 (en) Compositions used in dietetics, reanimation and therapeutics, containing a protein fraction based on 3 types of minipeptides, and their applications
BR9814766A (pt) Formulação de revitalização
AU554891B1 (en) Painkilling composition comprising calcium gluconate, pantothenic acid, vitamins b6 and c and magnesium hydroxide
FR2053703A5 (en) Supplementary food for pregnant women
RU93012680A (ru) Белково-витаминно-минеральная добавка для свиней
Summers Amino acid digestibility and utilization of protein sources by poultry
AU1706583A (en) Amino acid solutions for parenteral nutrition and methods of formulation and use
CA777750A (en) Nutritional utilization of amino acid amides and acid salts thereof
FI853504L (fi) Acetyldikarnitin.
IT8709448A0 (it) Associazioni di sali di calcio, vitamina d e aminoacidi in opportune forme farmaceutiche impiegabili nella profilassi e terapia dell'invecchiamento
PH21347A (en) N-(vinblastinoyl-23) derivatives of amino acids and pharmaceutical composition

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SYNTHELABO

Owner name: THE JOHNS HOPKINS UNIVERSITY